These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8189554)

  • 21. Oncogenes and growth factors in renal cell carcinoma.
    Peter S
    Urol Int; 1991; 47(4):199-202. PubMed ID: 1781103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular biology of Wilms' tumor.
    Koo HP; Hensle TW
    Urol Clin North Am; 1993 May; 20(2):323-31. PubMed ID: 8388135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic factors affect tumor initiation, progression and recurrence.
    Maranchie JK
    J Urol; 2014 Nov; 192(5):1318-9. PubMed ID: 25130530
    [No Abstract]   [Full Text] [Related]  

  • 24. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.
    Lunec J; Challen C; Wright C; Mellon K; Neal DE
    Lancet; 1992 Feb; 339(8790):439-40. PubMed ID: 1346710
    [No Abstract]   [Full Text] [Related]  

  • 25. Gene therapy--the future is here: a guide to the practicing urologist.
    Naitoh J; Belldegrun A
    Urology; 1998 Mar; 51(3):367-80. PubMed ID: 9510338
    [No Abstract]   [Full Text] [Related]  

  • 26. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors.
    Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A
    J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma.
    Sun CQ; Arnold R; Fernandez-Golarz C; Parrish AB; Almekinder T; He J; Ho SM; Svoboda P; Pohl J; Marshall FF; Petros JA
    Cancer Res; 2006 Sep; 66(17):8542-9. PubMed ID: 16951166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple tumor suppressor genes in multistep carcinogenesis.
    Feinberg AP; Johnson LA; Law DJ; Kuehn SE; Steenman M; Williams BR; Thomas G; Boland CR; Rainier S; Koi M
    Tohoku J Exp Med; 1992 Oct; 168(2):149-52. PubMed ID: 1339099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional loss of chromosome 6 in two urological malignancies.
    Rukstalis DB; Bubley GJ; Donahue JP; Richie JP; Seidman JG; DeWolf WC
    Cancer Res; 1989 Sep; 49(18):5087-90. PubMed ID: 2766279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
    Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
    Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of urological cancers.
    Maher ER
    Br Med Bull; 1994 Jul; 50(3):698-707. PubMed ID: 7987649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of the chromosome 11p region in renal cell carcinomas.
    Kovacs G; Kiechle-Schwarz M; Scherer G; Kung HF
    Cell Mol Biol; 1992 Feb; 38(1):59-62. PubMed ID: 1348450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitance of urogenital with lymphoid and intestinal malignancies: more than a coincidence.
    Shabtai F; Lask D; Kimchi D; Hart J; Halbrecht I
    Urol Int; 1985; 40(3):145-7. PubMed ID: 4040290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1995 Jan; 55(2):224-7. PubMed ID: 7812948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. H19 in normal development and neoplasia.
    Looijenga LH; Verkerk AJ; De Groot N; Hochberg AA; Oosterhuis JW
    Mol Reprod Dev; 1997 Mar; 46(3):419-39. PubMed ID: 9041146
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recent discoveries of cancer genes: what are the consequences for public health?].
    Bonaïti-Pellié C
    Rev Epidemiol Sante Publique; 1995; 43(2):105-6. PubMed ID: 7732196
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular genetics of skin cancer.
    Walsh DS
    Adv Dermatol; 1997; 13():167-204. PubMed ID: 9551144
    [No Abstract]   [Full Text] [Related]  

  • 39. Nonreciprocal chromosome translocation t(5;14) in cancers of the kidney: adenocarcinoma of the renal parenchyma and transitional cell carcinoma of the kidney pelvis.
    Hecht F; Berger CS; Sandberg AA
    Cancer Genet Cytogenet; 1985 Jan; 14(3-4):197-203. PubMed ID: 3967206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular pathology of urological malignancies.
    Dorkin TJ; Robson CN; Neal DE
    J Pathol; 1997 Dec; 183(4):380-7. PubMed ID: 9496253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.